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Introduction
The endoplasmic reticulum (ER) regulates protein synthesis, protein folding and trafficking, cellular responses to stress and intracellular calcium (Ca 2+ ) levels (Rao et al., 2004) . The conditions which impair the function of the ER, designated 'ER stress', can lead to an accumulation of unfolded or malfolded proteins in the ER lumen (Kaufman, 1999) . In response to ER stress, cells have developed a self-protective signal transduction pathway termed the unfolded protein response (UPR), which includes the induction of molecular chaperones in the ER, translational attenuation and ER-associated degradation (ERAD) (Cudna and Dickson, 2002) . However, if the damage is too severe to repair, the UPR ultimately initiates an apoptotic pathway (Cudna and Dickson, 2002; Oyadomari et al., 2002; Breckenridge et al., 2003) . ER stress-induced cell death has been shown to involve the activation of caspase-12 (Nakagawa et al., 2000; Nakagawa and Yuan, 2000) . Another component of the ER stress-mediated apoptotic pathway is C/EBP homologous protein (CHOP), also known as growth arrest-and DNA damage-inducible gene 153 (GADD153) (Wang et al., 1996) .
Cerebral ischemia is a pathophysiological ER stressor (Paschen and Doutheil,
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JPET # 69088 5 1999; Kumar et al., 2003) . Several studies have shown that ischemic injury causes a severe impairment of ER function, which in turn triggers shutdown of protein translation and apoptosis (Tajiri et al., 2004; Kumar et al., 2003) , suggesting that the ER plays an important role in cerebral ischemia. Thus, reducing ER stress may provide a therapeutic way to block the pathological process induced by cerebral ischemia.
Edaravone (3-Methyl-1-phenyl-2-pyrazolin-5-one) is a potent and novel scavenger of free radicals inhibiting not only hydroxyl radicals but also free radical-mediated lipid peroxidative damage (Watanabe et al., 1997) . It has been reported that edaravone changes into 2-oxo-3-(phenylbudrazono)-butanoic acid after reacting with peroxy radicals in vitro (Yamamoto et al., 1996) .
Edaravone has protective effects on cerebral edema and tissue injury after ischemia-reperfusion in rats (Abe et al., 1998) and patients with acute cerebral ischemia (Houkin et al., 1998; Mitsumori et al., 1998) . Additionally, edaravone protects against mitochondrial injury in hepatic and myocardial ischemia/reperfusion (Okatani et al., 2003; Rajesh et al., 2003) , and inhibits inflammatory reaction (Kono et al., 2003) . These effects were predominantly thought to be a result of the protective action of edaravone against lipid This article has not been copyedited and formatted. The final version may differ from this version. In the present study, we focused on the possible protective effect of edaravone against ER dysfunction. We obtained evidence that edaravone significantly inhibited ER stress-mediated apoptotic signals induced by hypoxia/ischemia and attenuated ER stress in vivo and in vitro.
Materials and Methods
Edaravone was a gift from Mitsubishi Chemical Industries, Japan. The drug was dissolved in NaOH (1 M), and adjusted to pH 7.4 according to the manufacturer's instructions. Tunicamycin was purchased from Wako Chemical Industries, Japan. NAC (N-acetyl-L-cysteine) and ebselen were purchased from Sigma.
Induction of hypoxia/ischemia
Male C57BL mice (6 weeks old) were anesthetized with halothane (2% in 70% N 2 O: 30% O 2 ), and the right carotid artery was isolated and double ligated with 4-0 surgical thread. The incision was sutured, and the animals were allowed to recover with access to food and water for 3 h. To induce hypoxia, This article has not been copyedited and formatted. The final version may differ from this version. JPET # 69088 7 each animal was placed in a 500-ml glass jar partially submerged in a temperature-controlled water bath and exposed to a humidified gas mixture of 6% O 2 / balance N 2 for specific intervals of 30 min. The water bath temperature was maintained at 35.5°C, which in previous experiments was shown to maintain the animals′ core body temperature at 37.5-37.7°C
throughout the hypoxic interval (Vannucci et al., 2001) . Animals were allowed to recover in room air for 30 min and then returned to their cages with free access to food and water. The rectal temperature was measured at several points during the initial hours after hypoxia/ischemia, and the longer intervals until they are killed. Animals in which the right common carotid artery was separated but no ligation and hypoxia were performed were used as sham-operated controls.
All animal experiments were carried out in accordance with the NIH Guide for Care and Use of Laboratory animals and were approved by the animal care and use committee of Hokkaido University.
Determination of infarct volume and hemispheric swelling
Animals were sacrificed 3 days after hypoxia/ischemia, and the brain was removed and cut into four 2-mm sections. The brain slices were immersed in a was used to determine the infracted volume (MV), right hemisphere volume (RV) and left hemisphere volume (LV). To compensate for the effect of brain edema on the measured infarct volume in the ischemic hemisphere, the infarct volume in each mouse was corrected as described (Aspey et al., 1998; Swanson et al., 1990) with the following formula. Corrected infarct volume (%) = [LV − (RV− MV)] / LV × 100. Hemispheric swelling in the ischemic hemisphere was also calculated: swelling (%) = RV− LV / LV × 100.
Evaluation of neurological status
Neurological deficits of mice at 1, 2 and 3 days after hypoxia/ischemia were assessed and scored as described (Huang et al., 1994) 
Cell culture
Primary glial cells were prepared from the whole brain of neonatal (<24 h) C57BL/6 mice as described previously (Hosoi et al., 2000) . The cells were allowed to grow to confluency in Dulbecco's modified Eagle's medium (DMEM) with 10% (v/v) fetal calf serum, 100 units/ml of penicillin G, and 100 µg/ml of streptomycin (Invitrogen). All cultured cells were maintained at 37ºC in 5% CO 2 -95% air.
RT-PCR
Total RNA was isolated from mouse brain or cultured cells using TRI REAGENT (Sigma, St. Louis, MO). RT-PCR was performed as described previously (Hosoi et al., 2002a) . The following primers were used: CHOP forward, 5'-ccc tgc ctt tca cct tgg-3'; CHOP reverse, 3'-ccg ctc gtt ctc ctg ctc-5';
XBP-1 forward, 5'-cct tgt ggt tga gaa cca gg-3'; XBP-1 reverse, 3'-cta gag gct tgg tgt ata c-5' ; GAPDH forward, 5'-gat gga gca tca tac tga tcc-3'; GAPDH This article has not been copyedited and formatted. The final version may differ from this version. 
Western blotting
Primary antibodies used for Western blotting analysis were as follows:
anti-phospho-eIF2α (Ser51) 
Measurement of intracellular reactive oxygen species (ROS)
A cell membrane-permeable and oxidant-sensitive fluorescent dye
was used to measure ROS. Tunicamycin (10 µM)-treated or untreated glial cells were washed with pre-warmed (37 °C) phosphate-buffered saline once and then incubated in culture medium, together with CM-H 2 DCFDA (10 µM).
After 30 min of incubation, the cells were washed with pre-warmed medium This article has not been copyedited and formatted. The final version may differ from this version. 
Results

Edaravone protects against cerebral injury caused by hypoxia/ischemia
Treatment with edaravone (1∼10 mg/kg, i.p., once a day for three days)
immediately after hypoxia/ischemia dose-dependently decreased infarct volume on the third day following hypoxia/ischemia. Remarkable protection was achieved with 3 and 10 mg/kg of edaravone by 30% and 60% reduction in edema-corrected infarct volume, respectively (Fig. 1b) . However, no significant reduction in infarct volume was observed in mice dosed with 1 mg/kg (Fig. 1b) . Hemispheric swelling was also significantly decreased with a dose of 3 (40% reduction) and 10 mg/kg (60% reduction) under the same treatment conditions (Fig. 1c) .
This article has not been copyedited and formatted. The final version may differ from this version. In addition, we examined the effect of edaravone on the rectal temperature of mice in the model of hypoxia/ischemia. No significant change in body temperature was observed in saline-and edaravone (10 mg/kg)-treated groups during the experiment (Fig. 2) . These results indicate that the protective effect of edaravone on hypoxia/ischemia is not caused by hypothermia.
Edaravone improves neurological function
Treatment with edaravone (10 mg/kg) significantly reduced neurological deficits and provided functional recovery from hypoxia/ischemia when examined at 24, 48 and 72 h, compared with the saline group (Fig. 3) .
Edaravone represses ER stress-mediated apoptotic signals
A key feature of ER stress induced by cerebral ischemia is the blocking of translation at the initiation step, as indicated by increased phosphorylation of eIF2α (Mengesdorf et al., 2002; DeGracia et al., 2002) . Therefore, we first 
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13 was markedly increased following hypoxia/ischemia and detectable until 12 h, whereas the administration of edaravone at 10 mg/kg noticeably reduced the levels from 6 to 12 h (approx 35% to 50% reduction, compared with the saline-treated group) (Fig. 4a ). No change in the level of phosphor-eIF2α
was observed in the brains of animals only injected with edaravone (Fig. 4d ).
In the previous study, we have observed that CHOP was significantly up-regulated in the hypoxia/ischemic cortex, hippocampus and striatum, and inductions of CHOP in the three regions show similar extent (unpublished observation). Quantification revealed a remarkable increase in the protein level of CHOP in the injured cortex 12 h after hypoxia/ischemia, compared with that in sham-operated animals. However, injection of edaravone remarkably down-regulated CHOP protein level (approx 90% reduction), compared with that in the saline-treated group (Fig. 4b) . The protein level of CHOP was not affected by treatment with edaravone in normal brains (Fig. 4d) .
Furthermore, Western blotting showed that hypoxia/ischemia led to the activation of caspase-12 as evidenced by a decrease in the level of the pro-caspase-12.
The activation of caspase-12 was largely restored by edaravone (almost 30% restoration, compared with the saline-treated group) ( (Fig. 4d) .
Edaravone attenuates ER stress in primary cultured glial cells
To elucidate the mechanism underlying the protection against ER dysfunction, first we evaluated the effect of edaravone on ER stress in primary cultured glial cells through treatment with ER stressor, tunicamycin (Tm, an inhibitor of N-glycoslytion). Western blotting analysis showed that treatment with Tm remarkably up-regulated the expression of GRP78 and CHOP, markers of ER stress response, whereas edaravone (1∼10 µM) dose-dependently inhibited GRP78 and CHOP induction ( Fig. 5a and b) .
XBP-1 mRNA has been shown to be spliced upon ER stress (Yoshida et al., 2001; Calfon et al., 2002) . We observed the splicing of XBP-1 mRNA 6 h after treatment with Tm (1 µg/ml). Edaravone inhibited or even abrogated XBP-1 mRNA splicing (Fig. 5c) , as reflected by a decrease in the ratio of spliced to unspliced forms of XBP-1.
In contrast to edaravone, NAC and ebselen, both of which have been demonstrated to be free radical scavengers, did not affect the induction of This article has not been copyedited and formatted. The final version may differ from this version. 6a and b) . Thus, the effect of inhibiting ER stress may be specific to edaravone.
Tm did not induce the increase in ROS levels in primary cultured glial cells
To determine whether the protective effect of edaravone on the ER results from resistance to ROS, which has been suggested to damage the ER and lead to cell death (Hayashi et al., 2003) , we assessed the levels of ROS under treatment with Tm in primary cultured glial cells. Tm did not generate ROS in glial cells (Fig. 6c) , suggesting that the inhibition of ER dysfunction by edaravone under conditions of Tm treatment may not be based on the radical scavenging action.
Discussion
In the present study, we used a murine model of hypoxia/ischemia. Thirty minutes of hypoxia/ischemia produced markedly damage to the ipsilateral cortex, hippocampus and striatum, as determined by TTC-staining. On the other hand, we showed that peripheral administration of edaravone protected brain from hypoxia/ischemic injury as evidenced by reduction in infarct volume and This article has not been copyedited and formatted. The final version may differ from this version. In cerebral ischemia, excessive generation of oxygen free radicals followed by lipid peroxidation is thought to play an important role in the secondary injury (Seki et al., 1998) . Exogenous radical scavengers have been demonstrated to suppress oxidative stress and thus prevent ischemic injury (Crompton, 1999; Zoratti and Szabo, 1995) . Edaravone has been shown to exert a protective effect against cerebral ischemic injury by inhibiting OH --and iron-dependent lipid peroxidations, both of which are essential in mediating ischemic cell damage (Watanabe et al., 1994) . On the other hand, ample evidence suggested that ER damage is involved in neuronal cell death induced by cerebral ischemia (Tajiri et al., 2004; Kumar et al., 2003) . Thus, in the present study, we investigated the effect of edaravone on ER dysfunction under pathological conditions. This article has not been copyedited and formatted. The final version may differ from this version. In mice subjected to 30 min hypoxia/ischemia followed by a given period of recovery, we observed an increase in the level of the transcription factor CHOP and activation of caspase-12 in the ischemic cortex. The results indicate that hypoxia/ischemia caused severe ER damage and triggered ER stress-associated apoptosis. On the other hand, treatment with edaravone significantly inhibited caspase-12 activation and CHOP induction. In addition, we observed suppression of phospho-eIF2α, upstream of CHOP. Therefore, the protective effects of edaravone in hypoxia/ischemic injury may be partly due to inhibition of ER stress and subsequent apoptotic signaling pathway.
We found that edaravone also inhibited ER stress even if the condition was non-ischemic. Treatment of cells with Tm, an inducer of ER stress, caused ER dysfunction as indicated by the induction of representative genes related to ER stress. However, Tm did not cause the production of ROS in primary cultured glial cells. Thus it was suggested that ER stress does not induce ROS production in glial cells. In addition, other free radical scavengers, such as NAC and ebselen, provided no protection against ER dysfunction. The results indicated that the property of inhibiting ER stress is specific to edaravone.
Thus, the protective effect of edaravone against hypoxia/ischemia may involve a This article has not been copyedited and formatted. The final version may differ from this version. 
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18 novel pathway which directly attenuates ER stress in addition to suppressing ROS production. Considering the findings of the present study, we speculate that edaravone has multiple effects, although the mechanism of its actions needs to be elucidated further.
In summary, the present results suggest that edaravone provided protection neurological deficits were assessed at 1, 2 and 3 days of recovery. Data are means ± S.E. from 10 mice in each group, respectively. *, p < 0.05 compared with the neurological score of the saline-treated group on the corresponding day, one-way ANOVA followed by Dunnett's test. 
